✦ LIBER ✦

THE RAPID DEVELOPMENT OF AN IgM INHIBITOR OF PORCINE FACTOR VIII IN A PATIENT WITH ACQUIRED HAEMOPHILIA

✍ Scribed by S. G. Weston Smith; P. Revell; A. S. Lawrie; L. J. Holland; G. F. Savidge

Book ID: 114712105
Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 256 KB
Volume: 75
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1990.tb04361.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful long-term treatment with porc

Successful long-term treatment with porcine factor VIII of a patient with haemophilia A and an inhibitor to factor VIII

✍ P. VYAS; K. J. PASI; C. A. LEE 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB

Successful management of a patient with

Successful management of a patient with an acquired factor VIII inhibitor

✍ Y. Sultan; P. Maisonneuve; A. Bismuth; A. Steg 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Development of Circulating Inhibitor Dir

Development of Circulating Inhibitor Directed against Factor VIII in Patients with Haemophilia-A

✍ COHN, JØRGEN ;NIELSEN, VAGN GERHARD 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 370 KB

Cross-reactivity to porcine factor VIII

Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New Zealand

✍ Lloyd, J. V. ;Street, A. M. ;Berry, E. ;McPherson, J. ;Ekert, H. ;Lammi, A. ;McW 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

Bleeding in the patient with a malignanc

Bleeding in the patient with a malignancy : Is it an acquired factor VIII inhibitor?

✍ Miguel A. Escobar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB

The economic impact of factor VIII inhib

The economic impact of factor VIII inhibitors in patients with haemophilia

✍ R. L. Bohn; L. M. Aledort; K. G. Putnam; B. M. Ewenstein; H. Mogun; J. Avorn 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

**Summary.** The impact on the cost of care for haemophilia patients with inhibitors is not well defined. To quantify the effect on health care expenditures associated with inhibitors to factor VIII (FVIII) or FIX, we conducted a retrospective cohort study examining product use and outcomes in adult